# Episode 222: Antibiotic Resistance

Page: https://stenobird.com/podcast/rio-bravo-qweek-508053/episode-222-antibiotic-resistance
Text version: https://stenobird.com/podcast/rio-bravo-qweek-508053/episode-222-antibiotic-resistance.md
Podcast: [Rio Bravo qWeek](https://stenobird.com/podcast/rio-bravo-qweek-508053)
Published: 2026-05-01T12:00:00+00:00
Episode link: https://rio-bravo-qweek.simplecast.com/episodes/episode-222-antibiotic-resistance-jlOrCmO_
Audio file: https://cdn.simplecast.com/media/audio/transcoded/3fc5af21-72c0-4090-b6f3-ffa15201221e/2669d47b-1a83-4e99-a326-10778e7c2687/episodes/audio/group/8aefdcb3-63a0-40f7-9932-547578348c1a/group-item/f36d9829-e553-4b11-9a23-ff7ac13a440b/128_default_tc.mp3?aid=rss_feed&feed=l3pUv9I_
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/rio-bravo-qweek-508053/episodes/episode-222-antibiotic-resistance
Duration seconds: 1064

## Resource

Episode 222: Antibiotic Resistance Mehr Boparai and Jeremy Pan, medical students, mention five common antibiotic-resistant bacteria and what the current treatments are. Dr. Arreaza asks questions to guide the presentation and adds an example of antibiotic resistance in a patient. Written by Mehr Boparai, OMS-III, and Jeremy Pan, OMS-III, Western University of Health Sciences, College of Osteopathic Medicine of the Pacific. Edits and comments by Hector Arreaza, MD.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/rio-bravo-qweek-508053/episodes/episode-222-antibiotic-resistance/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/rio-bravo-qweek-508053/episode-222-antibiotic-resistance.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.